* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 18 cents per share for the quarter ended in September. The
mean expectation of two analysts for the quarter was for a loss
of 21 cents per share.
* Reported revenue was zero; analysts expected $69.50
thousand.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 18 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Aethlon Medical Inc shares had fallen by 14.9% this
quarter and
lost 73.4% so far this year.
* The company reported a quarterly loss of $3.81 million.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 11:31 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.21 -0.18 Beat
Jun. 30 2022 -0.22 -0.19 Beat
Mar. 31 2022 -0.14 -0.26 Missed
Dec. 31 2021 -0.13 -0.16 Missed